In this study, we found that the levels of TLR-4, p-IκBα, and p-NF-κB p65 were upregulated in the COPD rats and downregulated by the administration of BY combined with EA, and the combined therapy significantly reduced the NF-κB DNA binding activity. Here, NFKB1 is linked to chronic obstructive pulmonary disease.